April 21, 2021 | Mia Scioscia Changes to State Price Transparency Reporting, Medicaid Laws Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers. Read More
April 14, 2021 | integrichain The Current State of Drug Price Transparency Reporting What you need to know about navigating a patchwork of state policies, achieving operational readiness, and avoiding compliance risk. Read More
March 11, 2021 | integrichain Changes to Medicare Part D, Drug Rebate Program, OIG Final Rule Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers. Read More
February 16, 2021 | integrichain New ASP Reporting Requirements, 340B Drug Pricing Program and Final Rule, HHS Formulary Rebate Rule Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers. Read More
January 28, 2021 | Mia Scioscia Five Steps to GTN Implementation Success Pharmaceutical manufacturers can achieve GTN implementation success on day one of a new product launch by following these five best practices. Read More
December 10, 2020 | Mia Scioscia Gross-to-Net Roadmap to Launch A comprehensive countdown of the Top 10 key gross-to-net (GTN) milestones for manufacturers about to launch their first commercial product. Read More
October 26, 2020 | Mia Scioscia GTN Analytics: Improve Visibility and Predictability of Your Forecasting and Accrual Processes Data on Demand, GTN Reporting, Trends, and Metrics. Find out what's new in the latest ICyte Platform GTN Analytics release. Read More
October 15, 2020 | integrichain Public Law Timeline for 2021, OIG Audit Report, Hot Topics at MDRP Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers. Read More
September 17, 2020 | integrichain Additional Drug Reporting for NDA and ANDA Holders, FDA NSDE Structured Product Labeling Updates Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers. Read More
August 11, 2020 | integrichain New Drug Pricing Executive Orders, Changes to 340B Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers. Read More
